A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Status:
Recruiting
Trial end date:
2025-06-26
Target enrollment:
Participant gender:
Summary
This study is a prospective, multicenter, open-label, single-arm effectiveness and safety
study in participants with progressive multiple sclerosis (PMS).